TFSA Investors: After Dropping Almost 50%, Is Canopy Growth (TSX:WEED) Stock Finally a Good Buy?

For TFSA investors looking for exposure to the cannabis industry, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is looking better today than it has in a long time.

| More on:

One year after legalization, Canopy Growth (TSX:WEED)(NYSE:CGC) still has got a lot of work to do to grow into its valuation and to secure its spot in the rapidly growing marijuana industry. The last year has not been good to cannabis stocks, as the bubble has finally burst, leaving shareholders reeling and potential investors spooked.

Naturally, a 50% drop in share price leaves us TFSA investors pondering whether new valuations are attractive enough to warrant establishing a position in this exciting stock and industry. To determine this, let’s take a look at what has changed besides the stock’s valuation and what this means for investors considering establishing a position.

Canopy Growth stock is still a speculative investment

Regardless of the high hopes for the cannabis industry, the fact remains that this space is experiencing many changes, the situation is very fluid, and visibility is limited beyond saying that this industry is one with high growth and great potential. How everything shakes up is less certain.

Canopy Growth has seen many changes in a short period of time, the latest big one being the ousting of CEO Bruce Linton by the board, which is controlled by Constellation Brands executives. So, here we are, with an interim replacement and the struggle to find the right permanent replacement.

The state of the industry is also highly uncertain, with the black market still thriving. A study released recently said that approximately 59% of marijuana users bought it illegally despite legalization, as the black market weed remains cheaper than legal weed.

Net losses are still high

As seen in the company’s latest quarterly result, net losses are still high. Further to this, company estimates as to when these losses will abate and the company will finally turn a profit are not so optimistic.

Net revenue increased a very strong 249% year over year, but the bottom line was once again disastrous, with a net loss of $1.28 billion and a 30% reduction in cash and cash equivalents to $3.1 billion. With these continued losses and necessary investments to support growth, Canopy Growth management recently admitted it will be another three to five years before the company is profitable.

So, with this, we can see that things will continue to be very volatile and risky in the short term.

Now for the rules of speculation

If, after all this, you are still inclined to buy Canopy Growth stock, we can at least say that today is a better time for you to this this than recent history. While 2019 estimates are still being reduced and the company will not turn a profit any time soon, at least the stock’s lofty valuation has come down a bit.

Now, remember the rules of speculation. Do not invest money that you can’t afford to lose. Invest only a small percentage of your total portfolio in speculative investments (do not exceed 10%). And once you’ve decided to invest, invest for the long term.

Foolish bottom line

Despite losing 50% of its value in the last year or so, Canopy Growth stock is still not for the faint of heart. One way to try to participate in this emerging, booming industry is to allocate a small portion of your TFSA to the group, which can include Canopy Growth stock as well as a couple of other cannabis stocks in order to diversify company-specific risk.

At the end of the day, high expectations, lofty valuations, and the lack of visibility in the cannabis industry have taken their toll. While we have not seen true “capitulation,” we are at least closer.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »